Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Drugs Expression-vector-encoding-hybrid-immunoglobulins

 Prevention of synovial adhesions
OF THE INVENTION A wide variety of lipid particles may include a nonsteroidal antiinflammatory ...


 Method for reducing unwanted cellular adhesions
In accordance with one aspect of the present invention there is provided a method for reducing ...


 Anti-infective and anti-inflammatory releasing systems for medical devices
Devices are provided having a polymer coating incorporating compounds inhibiting inflammation and ...


 Combined use of dopamine and serotonin agonists in the treatment of immune disorders
What is claimed is: 1. A method of treating a disorder to the immune system selected from the group ...


 Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor
OF THE INVENTION In accordance with the present invention, there are provided combinational ...


 Use of interleukin-4 receptors to inhibit biological responses mediated by interleukin-4
The present invention provides DNA sequences encoding mammalian Interleukin-4 receptors (IL-4R) or ...


 Surgical irrigation solution and method for inhibition of pain and inflammation
The present invention provides a solution constituting a mixture of multiple agents in low ...


 Method of treatment of osteoarthritis with interleuken-1 receptor antagonist
OF THE INVENTION As indicated hereinabove, the present invention is directed to both a method and ...


 Viral vectors to inhibit leukocyte infiltration or cartilage degradation of joints
The present invention has met the above described needs by providing methods for introducing at ...


 Surgical irrigation solution and method for inhibition of pain and inflammation
The present invention provides a solution constituting a mixture of multiple agents in low ...


 Expression vector encoding hybrid immunoglobulins

Details
Inventors: Capon, Daniel J.; Lasky, Laurence A.;
Assignee: Genentech, Inc. (San Francisco, CA)
Primary Examiner: Draper; Garnette D.
Assistant Examiner: Ulm; John D.
Attorney, Agent or Firm: Dreger; Ginger R.

Novel polypeptides are provided, together with methods for making and using them, and nucleic acids encoding them. These polypeptides are useful as cell surface adhesion molecules and ligands, and are useful in therapeutic or diagnostic compositions and methods.

DETAILED DESCRIPTION Ligand binding partners as defined herein are proteins known to function to bind specifically to target ligand molecules, and are generally found in their native state as secreted or membrane bound polypeptides; membrane-bound ligand binding partners typically include a hydrophobic transmembrane region or phospholipid anchor.
Ligand binding partners include receptors and carrier proteins, as well as hormones, cellular adhesive proteins (proteins which direct or induce the adhesion of one cell to another), lectin binding molecules, growth factors, enzymes, nutrient substances and the like.
CD antigens which are not members of the immunoglobulin gene superfamily or otherwise excluded as set forth above are suitable ligand binding partners, Knapp et al.
, Immunology Today 10 (8):253-258, 1989, specifically incorporated by reference.
The platelet growth factor receptor and insulin receptor may optionally be ligand binding partners.
Ligand binding partners include not only the full length native form, but truncations or other amino acid sequence variants that remain capable of binding to the normal ligand.
As used herein, the term "ligand binding partner" specifically excludes polymorphic and nonpolymorphic members of the immunoglobulin gene superfamily, and proteins which are homologous thereto, such as class I and class II major histocompatibility antigens, immunoglobulins, T-cell receptor .
alpha.
.
beta.
, .
gamma.
and .
delta.
chains, CD1, CD2, CD4, CD8, CD28, the .
gamma.
, .
delta.
and .
epsilon.
chains of CD3, OX-2, Thy-1, the intercellular or neural cell adhesion molecules (I-CAM or N-CAM), lymphocyte function associated antigen-3 (LFA-3), neurocytoplasmic protein (NCP-3), poly-Ig receptor, myelin-associated glycoprotein (MAG), high affinity IgE receptor, the major glycoprotein of peripheral myelin (Po), platelet derived growth factor receptor, colony stimulating factor-1 receptor, macrophage Fc receptor, Fc gamma receptors and carcinoembryonic antigen.
Homologous to a member of the immunoglobulin gene superfamily, for the purposes of this exclusion only, means having the sequence of a member of the immunoglobulin gene superfamily or having a sequence therewithin which has substantially the same (or a greater degree of) amino acid sequence homology to a known member of the superfamily as the specific examples given above have to the sequence of an immunoglobulin variable or constant domain



Related patents
  Hybrid immunoglobulins
Ligand binding partners as defined herein are proteins known to function to bind specifically to target ligand molecules, and are generally found in their native state ...
  GPIb-lipid complex and uses thereof
What is claimed is: 1. A complex comprising a lipid and a conjugate of GPIb or a GPIB fragment having a von Willebrand factor-binding capability that is almost at the ...
  Immuno-modulating antitumor activities of Ganoderma lucidum (Reishi) polysaccharides
We claim: 1. A composition comprising one or more fractions, the one or more fractions obtainable by a process comprising: homogenizing tissue of Ganoderma lucidum; ...
  Administration of "active" chondroitin sulfate A and "active" chondroitin sulfate C or mixtures thereof to mammals including humans
I claim: 1. The method which comprises the administration of "active" chondroitin sulfate A (CSA), "active" chondroitin sulfate C (CSC), or mixtures thereof to mammals ...
  Painless electrolyte solutions
What is claimed is: 1. A composition consisting of: (a) electrolytes selected from the group consisting of K.sup.+, Ca.sup.++, Na.sup.+ and Mg.sup.++ salts of anions, ...
  Method for enhancing healing of corneal endothelial wounds
Method using a non-steroidal antiinflammatory compound, such as indomethacin, and/or a growth factor that causes a change in cell function when bound to a cell surface ...
  Method and agents for promoting wound healing
In accordance with the present invention, diagnostic and therapeutic protocols are proposed that are predicated in part on the discovery that certain cytokines have been ...
  Control of post-surgical intraocular pressure using clonidine derivatives
OF THE INVENTION The present invention utilizes certain clonidine derivatives, as defined above, to control intraocular pressure of the eye during invasive or non-...
  Tissue irrigating solution
OF THE PREFERRED EMBODIMENTS The present invention is directed generally to an improved technique for packaging a tissue irrigating solution of the type which includes ...
  Indolyl substituted hydroxylamine derivatives
OF THE INVENTION More particularly the invention relates to the compounds of formula I ##STR2## wherein R represents hydrogen, lower alkyl, aryl, biaryl, C.sub.3 -C.sub....

0.014

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved